FibroBiologics Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
FBLG$0.96-2.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
| Item 8. | Financial Statements and Supplementary Data |
|---|
The financial statements required by this item are attached to this Form 10-K beginning with page F-1, and is incorporated here by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.